Neogen Chemicals Ltd
Neogen Chemicals Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Battery chemical revenue is expected to grow from ~INR 30-40 crore in FY26 to INR 400-500 crore in FY27. Full utilization at Dahej plant targeted next year (FY27) with standalone revenue around INR 950-1,000 crore and EBITDA margin ~18% ±1.5%. - As capacity utilization improves (FY28 onwards), margin improvement expected driven by CSM and organolithium business contributions. - Neogen Ionics targets 20% ROCE with EBITDA margin fluctuating between 16%-20% depending on lithium and raw material prices. - Battery chemicals (electrolyte + salt) revenue expected to grow from INR 30-40 crore in FY26 to INR 400-500 crore in FY27. - By FY28-FY29, potential to double revenues driven by greenfield expansions targeting INR 2,400-2,900 crore in battery chemicals segment. - Overall business expects double-digit growth beyond FY27 by optimizing current plants without major capex. - Insurance claims and plant rebuild costs affecting near-term profits but expected to normalize post FY27.
From Neogen Chemicals Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Battery chemical revenue is expected to grow from ~INR 30-40 crore in FY26 to INR 400-500 crore in FY27.
- Full utilization of battery chemical capacity is targeted by FY29, with revenue potential between INR 2,400 crore and INR 2,900 crore.
- Base business revenue is on track for INR 950-1000 crore in FY27 and aims for double-digit growth by FY28 without new capex through plant optimization.
- Electrolyte and electrolyte salt demand expected to be very strong by FY28-FY29, potentially requiring capacity expansions.
- Incremental electrolyte salt capacity of 2 KTA can be added within 9-12 months; an additional 5 KTA possible in 15-18 months if demand persists.
2 more points from Neogen Chemicals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Neogen Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Completed capex so far: ~INR 620 crore; expected INR 500 crore by end of current year.
- Total capex by next year: INR 1,500 crore across Dahej and Pakhajan sites.
- Neogen Chemicals rebuilding plant with potential incremental capex post insurance evaluation, mostly double-digit crores, no large capex planned next 1-2 years.
- Neogen Ionics: Majority of funding secured via 70% debt and JV partner equity; minimal further investment expected from Neogen standalone.
- Capacity expansions at electrolyte salt:
- 2 KTA expansion within 9-12 months (debottlenecking).
- Additional 5 KTA expansion possible in 15-18 months.
- Room for further 10 KTA with ~18 months lead time.
- Capex phased to align with customer contracts and approvals.
2 more points from Neogen Chemicals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Neogen Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Customers are currently deciding between sourcing electrolyte salt locally or importing electrolyte directly from China.
- The choice depends on cost competitiveness, local production restrictions (e.g., PLI scheme), and business stability preferences.
- The company has the option to supply electrolyte salt either from their Indian capacity or via JV partner's plant in China.
- Demand visibility is expected to become clearer over the next 12 to 15 months as customers finalize their sourcing decisions.
- The company anticipates strong electrolyte salt demand by FY28-FY29, which may require additional capacity expansion.
2 more points from Neogen Chemicals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Neogen Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹247 Cr, net profit ₹11 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Neogen Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- Galaxy Surfactants Ltd (Q2 FY26)
Capital Work-in-Progress (CWIP) was around INR 260 crores as of FY '25. Key concall takeaways from Galaxy Surfactants Ltd's Q2 FY26 earnings call — and how it…
- Vishnu Chemicals Ltd (Q2 FY26)
Q2FY26 operating revenues: ₹401.1 Cr, a 16.7% year-on-year (YoY) increase from ₹343.8 Cr in Q2FY25. Key investor presentation takeaways from Vishnu Chemicals Lt
- Fine Organic Industries Ltd (Q2 FY26)
Revenue from Operations (Consolidated) for Q2FY26: Rs 597.3 Cr, a 0.2% YoY increase from Rs 595.8 Cr in Q2FY25 (Page 36). Key investor presentation takeaways fr
Arthneeti Pro · Annual
Neogen Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Neogen Chemicals Ltd Q2 FY26 results?
Battery chemical revenue is expected to grow from ~INR 30-40 crore in FY26 to INR 400-500 crore in FY27. Full utilization at Dahej plant targeted next year (FY27) with standalone revenue around INR 950-1,000 crore and EBITDA margin ~18% ±1.5%. - As capacity utilization improves (FY28 onwards), margin improvement expected driven by CSM and organolithium business contributions. - Neogen Ionics targets 20% ROCE with EBITDA margin fluctuating between 16%-20% depending on lithium and raw material prices. - Battery chemicals (electrolyte + salt) revenue expected to grow from INR 30-40 crore in FY26 to INR 400-500 crore in FY27. - By FY28-FY29, potential to double revenues driven by greenfield expansions targeting INR 2,400-2,900 crore in battery chemicals segment. - Overall business expects double-digit growth beyond FY27 by optimizing current plants without major capex. - Insurance claims and plant rebuild costs affecting near-term profits but expected to normalize post FY27.
What is Neogen Chemicals Ltd share price analysis?
Neogen Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 209.9 with a market cap of ₹7,464 Cr. Investors should review the full earnings analysis for detailed insights.
Is Neogen Chemicals Ltd planning capital expenditure?
Completed capex so far: ~INR 620 crore; expected INR 500 crore by end of current year.
Keep Neogen Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.